logo

For the Inventor, By the Inventor

Tokyo, Japan

Sato Pharmaceutical Co., Ltd.

Calculating rank
USPTO Granted Patents = 18

% Expired Patents = 16.7



Trademarks = 32

Forward Citations = 187

Loading Chart...
Loading Chart...

44 inventors (with patents filed for the assignee):

goldMedal Keita Nagai (5 out of 5 patents)

silverMedal Motoaki Baba (4 out of 5 patents)

bronzeMedal Shinichi Fujioka (4 out of 4 patents)

4.  Koh Nagasawa (4 out of 5 patents)

5.  Hirobumi Takahashi (4 out of 15 patents)

6.  Eri Kondoh (4 out of 4 patents)

7.  Yoshiki Itoh (4 out of 4 patents)

8.  Kenichi Tanaka (4 out of 48 patents)

9.  Yoshinori Ito (2 out of 75 patents)

10.  Kiyotaka Matsui (2 out of 2 patents)

11.  Masami Inuma (2 out of 2 patents)

12.  Masahiro Ito (2 out of 91 patents)

13.  Seiichi Sato (2 out of 52 patents)

14.  Sachie Sogo (2 out of 2 patents)

15.  Mitsutoshi Tatara (2 out of 2 patents)


18 patents:

1. 11738006 - Pharmaceutical composition containing antifungal agent as active ingredient (2023-08-29),
2. D985396 - Child-proof eye drop container (2023-05-09),
3. 11560602 - Primer set for detecting trichophyton gene by lamp method, kit including same, and method for detecting trichophyton using same (2023-01-24),
4. 11299329 - Application container (2022-04-12),
5. 11084792 - Method for producing difluoromethylene compound (2021-08-10),
6. 10898470 - Pharmaceutical composition containing antifungal agent as active ingredient (2021-01-26),
7. 9650380 - Difluoromethylene compound (2017-05-16),
8. 9512119 - Difluoromethylene compound (2016-12-06),
9. 9359350 - Ring-fused compound (2016-06-07),
10. 9125836 - Film preparation with rapidly dissolving property and flexibility (2015-09-08),
11. 8987473 - Ring-fused compound (2015-03-24),
12. D628490 - Eye drop container (2010-12-07),
13. D508858 - Container with cover (2005-08-30),
14. 6525066 - 4-oxoquinolizine antimicrobial having 2-pyridone skeleton as partial structure (2003-02-25),
15. 6316026 - Method and apparatus for manufacturing tablet capable of quick disintegration in oral cavity (2001-11-13),
Company Overview
Sato Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of innovative healthcare products. The company focuses on various therapeutic areas, including pain management and infectious diseases, leveraging advanced research methodologies to create effective solutions. Headquartered in Tokyo, Japan, Sato is committed to enhancing patient outcomes through its dedication to quality and innovation in pharmaceutical technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#1,414 in Tokyo

#3,125 in Japan

#34,263 in the World

Tokyo, JP
Tokyo, Japan

Sato Pharmaceutical Co., Ltd.

Forward Citations = 187

44 inventors:

goldMedal Keita Nagai (5 out of 5 patents)

silverMedal Motoaki Baba (4 out of 5 patents)

bronzeMedal Shinichi Fujioka (4 out of 4 patents)

4.  Koh Nagasawa (4 out of 5 patents)

5.  Hirobumi Takahashi (4 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sato Pharmaceutical Co., Ltd.. Retrieved from https://idiyas.com/company/sato-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…